Skip to main content

Research Repository

Advanced Search

All Outputs (1)

Oral ketamine vs placebo in patients with cancer-related neuropathic pain (2018)
Journal Article
Fallon, M. T., Wilcock, A., Kelly, C. A., Paul, J., Lewsley, L., Norrie, J., & Laird, B. J. A. (2018). Oral ketamine vs placebo in patients with cancer-related neuropathic pain. JAMA Oncology, 4(6), 870-872. https://doi.org/10.1001/jamaoncol.2018.0131

Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the pop... Read More about Oral ketamine vs placebo in patients with cancer-related neuropathic pain.